These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

184 related items for PubMed ID: 2071124

  • 1. Vaginal antibody of patients with trichomoniasis is to a prominent surface immunogen of Trichomonas vaginalis.
    Alderete JF, Newton E, Dennis C, Engbring J, Neale KA.
    Genitourin Med; 1991 Jun; 67(3):220-5. PubMed ID: 2071124
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Cysteine proteinase 30 (CP30) and antibody response to CP30 in serum and vaginal washes of symptomatic and asymptomatic Trichomonas vaginalis-infected women.
    Yadav M, Dubey ML, Gupta I, Malla N.
    Parasite Immunol; 2007 Jul; 29(7):359-65. PubMed ID: 17576365
    [Abstract] [Full Text] [Related]

  • 8. Monoclonal antibody to a major surface glycoprotein immunogen differentiates isolates and subpopulations of Trichomonas vaginalis.
    Alderete JF, Suprun-Brown L, Kasmala L.
    Infect Immun; 1986 Apr; 52(1):70-5. PubMed ID: 3514466
    [Abstract] [Full Text] [Related]

  • 9. Antibodies to Trichomonas vaginalis surface glycolipid.
    Bastida-Corcuera FD, Singh BN, Gray GC, Stamper PD, Davuluri M, Schlangen K, Corbeil RR, Corbeil LB.
    Sex Transm Infect; 2013 Sep; 89(6):467-72. PubMed ID: 23785040
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Specific IgA response, T-cell subtype and cytokine profile in experimental intravaginal trichomoniasis.
    Paintlia MK, Kaur S, Gupta I, Ganguly NK, Mahajan RC, Malla N.
    Parasitol Res; 2002 Apr; 88(4):338-43. PubMed ID: 11999021
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Preliminary studies on target antigens for the diagnosis of Trichomonas vaginalis infection.
    Deng HY, Lee JC, Chou SC, Wang GR.
    J Microbiol Immunol Infect; 1999 Mar; 32(1):14-20. PubMed ID: 11561565
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Use of a crude extract or a purified antigen of Trichomonas vaginalis for the detection of secretory antibodies by ELISA.
    Angeretti A, Merlino C, Savoia D, Martinotti MG.
    Microbiologica; 1988 Jan; 11(1):29-35. PubMed ID: 3258398
    [Abstract] [Full Text] [Related]

  • 19. Kinetics of immunoglobulin G, M, A and IgG subclass responses in experimental intravaginal trichomoniasis: prominence of IgG1 response.
    Yadav M, Gupta I, Malla N.
    Parasite Immunol; 2005 Dec; 27(12):461-7. PubMed ID: 16255745
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.